EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of early dexmedetomidine administration on short‐ and long‐term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC‐IV database

Yang Long iD, Long-Zhen Liu iD, Xiao-Xue Tan, Yong-Hu Zhang, Cheng-Xi Liu, Shan Liu, Wen-Jie Liu

Ibrain · 2026-03 · 12 (1) · 137-150

DOI: 10.1002/ibra.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ibrain, online erschienen am 11.03.2026. Verfasst von Yang Long und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School University of South China Hengyang China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Hunan Province, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI) causes significant mortality. Dexmedetomidine (DEX) shows neuroprotective potential in animals, but clinical evidence remains inconsistent. We evaluated the impact of early DEX, initiated within 48 h of admission with a treatment duration of at least 4 h, on survival in intensive care unit (ICU) patients with TBI using the Medical Information Mart for Intensive Care‐IV (MIMIC‐IV) database. Outcomes included 28‐day, hospital, and 1‐year mortality, analyzed via propensity score matching (PSM), multivariable Cox models, and subgroup analyses. Of 2378 patients, 241 received DEX. After PSM (235 pairs), early DEX use significantly reduced 28‐day (HR 0.45, 95% CI 0.30–0.69, p < 0.001) and hospital mortality (HR 0.25, 95% CI 0.15–0.42, p < 0.001). These results remained robust across sensitivity analyses. Similarly, 1‐year mortality decreased (HR 0.64, 95% CI 0.47–0.87, p < 0.01) and further supported by the Boruta algorithm, although inverse probability of treatment weighting analysis showed only a non‐significant trend ( p = 0.08). Survival benefits were more pronounced in patients aged

Schlagwörter

Stichwörter der Autor:innen

MIMIC‐IVearly dexmedetomidine administrationsurvival outcomestraumatic brain injury

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School University of South China Hengyang China.
  • Department of Emergency, The Second Affiliated Hospital, Hengyang Medical School University of South China Hengyang China.
  • The Second Affiliated Hospital, National Regional Key Cities and Sub-central Cities in Hunan Province Hengyang Academician and Expert International Academic Exchange High Tech University, Building A First-class Discipli…

ORCID-Profile: Yang Long, Long-Zhen Liu

Förderung

  • Health Commission of Hunan Province
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Long, Y., Liu, L. Z., Tan, X. X., Zhang, Y. H., Liu, C. X., Liu, S., & Liu, W. J. (2026). Impact of early dexmedetomidine administration on short‐ and long‐term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC‐IV database. Ibrain, 12(1), 137-150. https://doi.org/10.1002/ibra.70015

Vancouver

Long Y, Liu LZ, Tan XX, Zhang YH, Liu CX, Liu S, et al. Impact of early dexmedetomidine administration on short‐ and long‐term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC‐IV database. Ibrain. 2026;12(1):137-150. doi:10.1002/ibra.70015

BibTeX
@article{Long2026,
  author = {Long, Yang and Liu, Long-Zhen and Tan, Xiao-Xue and Zhang, Yong-Hu and Liu, Cheng-Xi and Liu, Shan and Liu, Wen-Jie},
  title = {Impact of early dexmedetomidine administration on short‐ and long‐term outcomes in critically traumatic brain injury patients: A retrospective study using the MIMIC‐IV database},
  journal = {Ibrain},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {137--150},
  doi = {10.1002/ibra.70015}
}
Kostenlos starten →